高知特(CTSH)
搜索文档
Here's Why Cognizant (CTSH) is a Strong Value Stock
Zacks Investment Research· 2024-04-05 22:46
Zacks Premium - Zacks Premium提供多种方式帮助投资者更聪明、更自信地投资[1] Zacks Style Scores - Zacks Style Scores是与Zacks Rank一起开发的补充指标,根据三种广泛关注的投资方法对股票进行评级[3] - Style Scores分为价值评分、成长评分、动量评分和VGM评分四个类别,帮助投资者找到具有最有吸引力的价值、最佳增长预测和最有前景动量的公司[5][6][7][8] Zacks Rank - Zacks Rank利用盈利预测修订的力量帮助投资者创建成功的投资组合[9] - 选择具有Zacks Rank 1或2且具有A或B评分的股票,以确保最大的上涨潜力[12] - 任何对公司盈利前景的变化都应成为选择购买股票的决定因素[13] - 拥有Zacks Rank 1或2和A或B评分的股票越多,越好[14] Cognizant (CTSH) - Cognizant (CTSH)是一家总部位于新泽西州的专业服务公司,目前在Zacks Rank上为3(持有),VGM评分为B[15] - CTSH具有吸引人的估值指标,如15.55的前瞻性P/E比率,值得价值投资者关注[16] - 过去60天内有四位分析师上调了对2024财年的盈利预期,Zacks Consensus Estimate上调了0.01美元至每股4.61美元,CTSH拥有10%的平均盈利惊喜[17]
Cognizant (CTSH), McCormik Team Up for Digital Transformation
Zacks Investment Research· 2024-04-04 00:36
Cognizant Technology Solutions (CTSH) recently inked a partnership with a global leader in the flavor industry, McCormik & Company (MKC) . The partnership aims to transform and manage McCormik’s global technology infrastructure, spanning 150 countries and territories worldwide.With a focus on delivering predictable business outcomes through AI automated tools, Cognizant aims to enhance user experiences for McCormik’s extensive workforce of approximately 13,000 employees across more than 80 global sites.Over ...
Cognizant signs a large, global infrastructure agreement with McCormick & Company, Inc.
Prnewswire· 2024-04-02 20:00
New agreement expected to help transform and manage global technology infrastructure, elevating employee and customer experiences TEANECK, N.J., April 2, 2024 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced a new agreement to transform and manage the global technology infrastructure of McCormick & Company, Inc. (NYSE: MKC), a global leader in flavor with a portfolio of category-leading brands that span 150 countries and territories around the world. The new agreement is expected to deliver predict ...
Cognizant (CTSH) Rides on Expanding Clientele, Partner Base
Zacks Investment Research· 2024-04-02 01:51
Cognizant Technology Solutions (CTSH) is benefitting from an expanding clientele and strong partner base. Its robust pipeline, which includes a favorable mix of business renewals and expansions of new opportunities, is noteworthy.The upside has been further bolstered by Cognizant’s continued improvement of large deal momentum, evidenced by winning several deals exceeding $100 million each in the fourth quarter of 2023.Building on this momentum, Cognizant recently announced a multi-year extension of its part ...
Cognizant (CTSH) Boosts Developer Productivity with Google Cloud
Zacks Investment Research· 2024-03-22 01:46
Cognizant与Google Cloud合作 - Cognizant与Alphabet的云业务Google Cloud扩大合作,加强在软件开发和人工智能领域的影响力[1] - 通过整合Gemini for Google Cloud,Cognizant与Google Cloud合作将改变软件交付生命周期,提高开发人员生产力[2] - Cognizant计划培训超过7万名员工使用Google Cloud的人工智能工具,以提高他们编写、测试和部署代码的效率[3] Cognizant的合作项目 - Cognizant与Cermaq Group AS合作,旨在现代化和增强技术基础设施,推动成本效益、加快产品推出速度和促进全球数字化转型[6] - Cognizant与NVIDIA合作推动生成式人工智能技术,改变药物发现和提高生命科学行业生产力[8] - Cognizant与微软合作将生成式人工智能整合到医疗行政管理中,提高效率和生产力,确保及时响应和改善患者护理[9] Cognizant的财务状况 - Cognizant预计金融服务领域的宏观环境将继续影响支出率,从而影响公司的营收增长[10] - Cognizant的股价较年初下跌0.5%,而Zacks计算机和技术部门上涨了10.3%[11] - 公司预计2024年第一季度营收在46.8亿至47.6亿美元之间,同比下降2.7%至1.2%[12] - 第一季度的Zacks共识估计为47.3亿美元,同比下降1.79%[13] - 盈利的共识估计为每股1.11美元,过去30天上涨了几分钱[14]
Cognizant and Google Cloud Expand AI Partnership to Drive Software Development Productivity
Prnewswire· 2024-03-21 12:01
合作内容 - Cognizant与Google Cloud合作,采用Gemini加速软件开发速度,让超过70,000名员工能够使用Google Cloud最新的人工智能技术[1] - 通过Gemini for Google Cloud,Cognizant的开发人员将能够更快、更有效地编写、测试和部署代码,提高建立和管理客户应用程序的可靠性和成本效率[2] - 通过与Google Cloud合作,Cognizant将投资10亿美元在三年内发展生成式人工智能,培训超过70,000名员工使用Google Cloud的人工智能产品,并将Gemini整合到自动化平台中[4]
Why Cognizant (CTSH) is a Top Value Stock for the Long-Term
Zacks Investment Research· 2024-03-20 22:41
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium includes access to the Zacks Style Scores as well.What are the Zacks Style Sc ...
Cermaq Extends Collaboration with Cognizant to Further Enhance Operational Efficiencies
Prnewswire· 2024-03-20 16:00
Cognizant will provide managed infrastructure services and seek to modernize Cermaq's cloud landscape as a digital transformation partner in Norway and Canada TEANECK, N.J., March 20, 2024 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) has today announced its renewed collaboration with Cermaq Group AS, a leading global salmon producer driving the transition of systems towards healthier and more climate-friendly foods. The renewal comes after an existing ten-year relationship between the two companies which has e ...
Cognizant (CTSH) Partners NVIDIA to Boost Life Sciences Footprint
Zacks Investment Research· 2024-03-20 00:16
Cognizant的合作伙伴关系 - Cognizant与NVIDIA和Microsoft合作,利用gen AI技术改变药物发现和医疗管理领域[1][2] - Cognizant与Microsoft合作将gen AI整合到医疗管理中,旨在提高效率和患者护理质量[5][6] - Cognizant的强大合作伙伴基础包括Microsoft、NVIDIA和ServiceNow,推动公司前景[7][10] - Cognizant与ServiceNow合作,增强WorkNEXT现代工作场所服务解决方案[9] - Cognizant与CNO Financial合作,优化技术服务和解决方案[10][11] gen AI技术的应用 - gen AI技术有望简化药物开发流程,提高生产力,加速治疗方案上市[4] - Cognizant推出了基于gen AI技术的创新助手,加强内部创新倡议[8] - Cognizant推出了Flowsource平台,采用gen AI技术,革新企业软件工程领域[12] 财务展望 - Cognizant预计2024年第一季度营收将下降,但市场预期仍保持稳定[13][14]
Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo
Prnewswire· 2024-03-19 12:01
Cognizant's AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors TEANECK, N.J., March 19, 2024 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) is advancing the application of generative AI (gen AI) technology with the NVIDIA BioNeMo platform to solve complex challenges of drug discovery in the life sciences industry, such as improving productivity in the development process and increasing the s ...